http://www.zibb.com/all/theme/cq/Amylin+Pharmaceuticals+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Mon, 19 Oct 2009 11:02:37 GMTMon, 19 Oct 2009 11:02:37 GMT608831http://www.zibb.com/all/theme/cq/Amylin+Pharmaceuticals+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.bio-medicine.org/medicine-technology-1/Amylin-Pharmaceuticals-Highlights-New-Data-Supporting-Therapeutic-Potential-of-Obesity-Pipeline-at-Obesity-2009-5568-1/...SAN DIEGO Calif. Oct. 19 2009 /- Amylin Phar...Amylin will also present new scientific findings from preclinical stud... The discovery of leptin and its role along with other endocrine sign... Key Amylin Activities at Obesity 2009:http://www.bio-medicine.org/medicine-technology-1/Amylin-Pharmaceuticals-Highlights-New-Data-Supporting-Therapeutic-Potential-of-Obesity-Pipeline-at-Obesity-2009-5568-1/Amylin Pharmaceuticals IncorporatedMon, 19 Oct 2009 11:02:37 GMThttp://www.biospace.com/company_profile.aspx?CompanyId=1734Amylin Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving lives through the discovery, development, and commercialization of innovative medicines.http://www.biospace.com/company_profile.aspx?CompanyId=1734Amylin Pharmaceuticals Incorporatedhttp://www.researchandmarkets.co.uk/reportinfo.asp?report_id=222735Our Amylin Pharmaceuticals, Inc. Company Profile is the essential source for top-level company data and information. The report examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.http://www.researchandmarkets.co.uk/reportinfo.asp?report_id=222735Amylin Pharmaceuticals Incorporatedhttp://www.drugs.com/NDA/symlin_040930.htmlDrugs.com - prescription drug and over the counter medicine information available on over 24,000 approved medications and pharmaceuticals, including side effects and drug interactions.http://www.drugs.com/NDA/symlin_040930.htmlAmylin Pharmaceuticals Incorporatedhttp://www.californiabiotechlaw.com/archives/145615-print.htmlGenentech's rejection of Roche's $43.7 billion offer last week, coverage of the fallout from the "failed" bid continues as industry observers speculate on Roche's next move.http://www.californiabiotechlaw.com/archives/145615-print.htmlAmylin Pharmaceuticals Incorporatedhttp://www.evaluatepharma.com/CoInfo/CoInfo-AMY.htmEvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.http://www.evaluatepharma.com/CoInfo/CoInfo-AMY.htmAmylin Pharmaceuticals Incorporatedhttp://www.quotelinks.com/companies/amln.htmlStock earnings, recommendations and SEC filings for Amylin Pharmaceuticals, Inc.http://www.quotelinks.com/companies/amln.htmlAmylin Pharmaceuticals Incorporatedhttp://www.newratings.com/headlines/Amylin-Pharmaceuticals_US0323461089.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/Amylin-Pharmaceuticals_US0323461089.htmlAmylin Pharmaceuticals Incorporatedhttp://www.fiercebiotech.com/node/5456FierceBiotech is the biotech industry daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and fda approval news.http://www.fiercebiotech.com/node/5456Amylin Pharmaceuticals Incorporatedhttp://www.computerbusinessreview.com/companyprofile.asp?guid=D1B26C6F-2FEE-4718-B563-1E930B810BBB** NEW FEATURE ** Sign-up for NewsAlerts on Amylin Pharmaceuticals, Inc. so that whenever news breaks on this company you are amongst the first to know. Click here...http://www.computerbusinessreview.com/companyprofile.asp?guid=D1B26C6F-2FEE-4718-B563-1E930B810BBBAmylin Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=7536. Ginger L. Graham, President and Chief Executive Officer of Amylin Pharmaceuticals, will be providing a corporate overview at the Bear Stearns Confab.http://www.pharmacychoice.com/News/article.cfm?Article_ID=7536Amylin Pharmaceuticals Incorporatedhttp://www.alkermes.com/newsroom/showArticlePrintView.aspx?id=22AC2993 is being developed by Amylin as a potential treatment for type 2 diabetes. The study is being conducted by Alkermes in Europe, and is being funded by Amylin.http://www.alkermes.com/newsroom/showArticlePrintView.aspx?id=22Amylin Pharmaceuticals Incorporatedhttp://www.diabetes.org/diabetes-research/ADA-Research-Foundation/amylin.jspThe American Diabetes Association (ADA) Research Foundation is pleased to count Amylin Pharmaceuticals, Inc. as a partner in the mission to prevent and cure diabetes.http://www.diabetes.org/diabetes-research/ADA-Research-Foundation/amylin.jspAmylin Pharmaceuticals Incorporatedhttp://www.researchandmarkets.com/reports/551590/isis_pharmaceuticals_inc_swot_analysisOur Isis Pharmaceuticals, Inc. Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.http://www.researchandmarkets.com/reports/551590/isis_pharmaceuticals_inc_swot_analysisAmylin Pharmaceuticals Incorporatedhttp://www.thelabrat.com/jobs/companies/AmylinPharmaceuticals.shtmlAmylin Pharmaceuticals, Inc. is a development pharmaceutical company focused on metabolic disorders with a concentration in diabetes.http://www.thelabrat.com/jobs/companies/AmylinPharmaceuticals.shtmlAmylin Pharmaceuticals Incorporatedhttp://www.mongabay.com/health/medications/Byetta.htmlThis page contains recent news articles, when available, and an overview of Byetta but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.http://www.mongabay.com/health/medications/Byetta.htmlAmylin Pharmaceuticals Incorporatedhttp://www.stockhouse.ca/comp_database/morenews.asp?symbol=AMLN&table=LISTU.S. Equity News: Amylin & Eli Lilly Announces FDA Approval of Combinational Use of Byetta Injection and BioMarin Calls Remaining $51.http://www.stockhouse.ca/comp_database/morenews.asp?symbol=AMLN&table=LISTAmylin Pharmaceuticals Incorporatedhttp://www.datamonitor.com/companies/company/?pid=D1B26C6F-2FEE-4718-B563-1E930B810BBBAmylin Pharmaceuticals (Amylin) is engaged in the discovery, development and commercialization of potential drug candidates for the treatment of diabetes and obesity.http://www.datamonitor.com/companies/company/?pid=D1B26C6F-2FEE-4718-B563-1E930B810BBBAmylin Pharmaceuticals Incorporatedhttp://www.lilly.com/about/partnerships/profiles/amylin/Amylin and Lilly are working together to develop a once-weekly, long-acting formulation of exenatide, a subcutaneous injection of exenatide for the treatment of type 2 diabetes.http://www.lilly.com/about/partnerships/profiles/amylin/Amylin Pharmaceuticals Incorporatedhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=102018&category=17Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=102018&category=17Amylin Pharmaceuticals Incorporatedhttp://www.electronicwatercooler.com/companies/company_main.jsp?product_id=36449&co_page=13&type=interviewAmylin Pharmaceuticals Interview & Recruiting Surveys are detailed accounts of the recruiting/hiring process and interviews at null (how many rounds of interviews, who conducted the interviews, and whether there were any specific interview questions you remember of note).http://www.electronicwatercooler.com/companies/company_main.jsp?product_id=36449&co_page=13&type=interviewAmylin Pharmaceuticals Incorporatedhttp://www.bio-medicine.org/medicine-news-1/Amylin-Pharmaceuticals-and-Takeda-Enter-into-Worldwide-Agreement-to-Co-Develop-and-Commercialize-Compounds-for-Obesity-60478-1/Health,...SAN DIEGO and OSAKA Japan Nov. 1 2009 /- Amy...The agreement includes products to be developed from Amylin's pipeline...Under the terms of the agreement Amylin will be responsible for execu...Takeda will lead product commercialization both in the U.S. andhttp://www.bio-medicine.org/medicine-news-1/Amylin-Pharmaceuticals-and-Takeda-Enter-into-Worldwide-Agreement-to-Co-Develop-and-Commercialize-Compounds-for-Obesity-60478-1/Amylin Pharmaceuticals IncorporatedSun, 01 Nov 2009 14:33:14 GMThttp://www.pharmacychoice.com/News/article.cfm?Article_ID=2959"With the recent approvals of two first-in-class diabetes medicines, SYMLIN and BYETTA, the remainder of 2005 is set up to be a year of transformation for Amylin Pharmaceuticals," said Ginger L. Graham, President and Chief Executive Officer, Amylin Pharmaceuticals, Inc.http://www.pharmacychoice.com/News/article.cfm?Article_ID=2959Amylin Pharmaceuticals Incorporatedhttp://www.bio-medicine.org/medicine-technology-1/Amylin-Pharmaceuticals-and-Eli-Lilly-and-Company-Statement-on-FDAs-BYETTA-28R-29--28Exenatide-29-Injection-Update-5921-1/...SAN DIEGO and INDIANAPOLIS Nov. 2 2009 /- Amy... The FDA update issued today aligns with the BYETTA label approved las...On October 30 the FDA approved an expanded indication for BYETTA ashttp://www.bio-medicine.org/medicine-technology-1/Amylin-Pharmaceuticals-and-Eli-Lilly-and-Company-Statement-on-FDAs-BYETTA-28R-29--28Exenatide-29-Injection-Update-5921-1/Amylin Pharmaceuticals IncorporatedMon, 02 Nov 2009 09:48:33 GMThttp://www.pharmacychoice.com/News/article.cfm?Article_ID=6537The live presentation will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at www.amylin.com.http://www.pharmacychoice.com/News/article.cfm?Article_ID=6537Amylin Pharmaceuticals Incorporated